A drug created and patented by a team of University of South Florida researchers is at the center of Thursday’s major deal between global pharmaceutical company AstraZeneca PLC and Targacept, Inc., potentially earning the university its most lucrative patent royalties to date…
Popularity: unranked [?]
Related posts:
- USF-Patented Drug Center Of Major Deal
- New TMS Clinic At Rush University Medical Center Offers Non-Invasive Treatment For Major Depression
- Social Form Of Bullying Linked To Depression, Anxiety In Adults
- Deep Brain Stimulation May Offer Hope For Select Patients With Treatment Resistant Major Depression
- MSU Becoming Center Of Excellence For Parkinson’s Research
Comments
No Responses to “USF-Patented Drug Center Of Major Deal”